FDA’s review of MDMA for PTSD highlights study bias and safety concerns

Beth Mole
June 1, 2024

Liked this post? Share with others!

FDA advisors will meet June 4 to discuss and vote on the therapy’s effectiveness…
Read More

Subscribe to our newsletter

Collect visitor’s submissions and store it directly in your Elementor account, or integrate your favorite marketing & CRM tools.

Do you want to boost your business today?

This is your chance to invite visitors to contact you. Tell them you’ll be happy to answer all their questions as soon as possible.